APA (7th ed.) Citation

FB, R., SW, C., C, L. L., GP, C., JV, M., VA, T., . . . NP, S. (2025). Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials. JACC. Advances, 4(2), 101549. https://doi.org/10.1016/j.jacadv.2024.101549

Chicago Style (17th ed.) Citation

FB, Rivera, et al. "Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors On Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials." JACC. Advances 4, no. 2 (2025): 101549. https://doi.org/10.1016/j.jacadv.2024.101549.

MLA (9th ed.) Citation

FB, Rivera, et al. "Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors On Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials." JACC. Advances, vol. 4, no. 2, 2025, p. 101549, https://doi.org/10.1016/j.jacadv.2024.101549.